Replies to post #24357 on $heff's $tation of $tocks & $olid DD

[cccpmd666]

This is bizzare. They are really shaking this, but no worries. PDUFA is coming up and I really feel that SOMX will hear a positive response.

GLTA

[imperativity]

The MMs are brutal with this one. They did action like this THREE times leading up to the December fourth date. I would wait it out for a day or two more as well!

[thefranchise]

SOMX unlikely to get approval, based on FDAs lack of kindness to sleep medications. See TSPT, and the many before it. Good short from these levels.

[chrisand813]

Health Stocks Fall, Hurting Dow
http://online.wsj.com/article/SB10001424052748703862704575099182351581808.html?ru=yahoo&mod=yahoo_hs

Stocks faltered, hurt by weakness in the health-care sector fueled by unpromising test results for a new Alzheimer's drug and a new call by President Obama to pass federal health-care legislation.

The market rose through most of the session, aided by favorable readings of jobs, service-sector activity, and the Federal Reserve's beige book of regional indicators. But the gains dried up late in the session.

The Dow Jones Industrial Average was up more than 60 points at its morning high but ended with a 9.22-point decline at 10396.76, off 0.3% for the year to date. The decline marked the second time in a row that the Dow failed to maintain an intraday rally that could have put it in the black for 2010.

Pfizer was the Dow's weakest component, off 1.6% after Medivation said its experimental Alzheimer's disease treatment Dimebon, which was in development with Pfizer, failed to show effectiveness in a large late-stage study. The news sent shares of Medivation, which is not a Dow stock, plunging 67.5.

Merck fell 0.5%, while Johnson & Johnson slipped 0.1% after posting gains early in the session.

The health-care sector's losses piled up late in the day after Mr. Obama said he is seeking to push the "long and wrenching debate" over health care into its final stages. Mr. Obama asked lawmakers to schedule a vote on overhaul legislation "in the next few weeks."

Health-care stocks have been sensitive to the possibility that any possible changes enacted in Washington might cut into private providers' profits. The sector picked up a bit in mid-January when Republicans picked up a 41st seat in the Senate—a development that was thought by many to dim the prospects of passage of a health bill. But investors had to reconsider the possibility that a bill might get through after all.

"A lot of the legislative news has already been priced into these stocks, so they're not exactly getting killed," said Todd Leone, head trader at Cowen & Co. "But at the same time, passage of any bill would be a negative for the sector if and when it happens. I think we're looking at about a 50-50 possibility of that at this point."

[Neil_B]

$heff, w/SOMX you have proved to me that you are a real human being like all of us. You are not a GOD whom the lesser think knows everything and can control everything. In my mind, that is a positive thing.

And that instills even more confidence in my mind. Because then the only thing that separates you from all the others is the knack and the solid DD that you share with all of us.

Lucky to have found this board and hope you continue to share your DD on stocks with us. Good luck to all!